{
    "clinical_study": {
        "@rank": "116022", 
        "arm_group": [
            {
                "arm_group_label": "Apremilast 30 mg", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether apremilast is safe and effective for\n      treating patients with psoriatic arthritis."
        }, 
        "brief_title": "Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis", 
        "completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Psoriatic Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Psoriatic"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a Phase 3b, multicenter, randomized, double-blind, placebo-controlled,\n      parallel-group study to evaluate the efficacy and safety of apremilast monotherapy in\n      subjects with active psoriatic arthritis.\n\n      Approximately 214 subjects will be randomized in a 1:1 ratio to either apremilast 30 mg BID\n      (twice a day) or identically-appearing placebo, with approximately 107 subjects per\n      treatment group.\n\n      This is a 113-week study.  The subjects will spend 24 weeks in the double-blind,\n      placebo-controlled treatment phase, followed by 28 weeks of active treatment phase (ie, up\n      to Week 52 visit).  The original treatment assignments (apremilast 30 mg BID (twice a day)\n      or placebo) will remain blinded until all subjects have completed their Week 52 visit (or\n      have discontinued).  After the Week 52 visit, all subjects in the extension phase will\n      continue to receive treatment with apremilast 30 mg BID (twice a day) until the end of the\n      study (ie, up to Week 104 visit) or until early discontinuation from the trial.\n\n      The study will consist of 5 phases:\n\n        1. Screening Phase - up to 5 weeks\n\n        2. Randomized, Placebo-controlled, Double Blind Treatment Phase - Weeks 0 to 24\n\n        3. Active Treatment Phase - Week 24 to Week 52\n\n        4. Open-label Extension Phase - Week 52 to Week 104\n\n        5. Post-treatment Observational Follow-up Phase"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  - 1. Males or females, 18 years and older at time of consent. 2. Must understand and\n             voluntarily sign an informed consent document prior to any study related\n             assessments/procedures being conducted.\n\n             3. Able to adhere to the study visit schedule and other protocol requirements. 4.\n             Have a documented diagnosis of psoriatic arthritis (by any criteria) of at least 3\n             months' duration 5. Meet the classification criteria for psoriatic arthritis (CASPAR)\n             at the time of screening.\n\n             6. Have at least 3 swollen AND at least 3 tender joints. 7. Must have high\n             sensitivity C-Reactive Protein (hs-CRP) of at least 0.5 mg/dL at screening and at\n             baseline.\n\n             8. Must be receiving treatment on an outpatient basis. 9. Must be tumor necrosis\n             factor (TNF) blocker naive and other Biologic na\u00efve for dermatologic and rheumatic\n             conditions 10. Subjects taking disease modifying anti-rheumatoid drugs (DMARDs), with\n             the exception of cyclosporine and leflunomide (see 7.3. Exclusion Criteria 20, 21),\n             do not require a washout, however, they must discontinue the DMARD treatment at least\n             one day prior to their baseline visit (ie, Visit 2, Day 0) 11. Subjects who have been\n             previously treated with leflunomide will require a 12-week washout or treatment with\n             the cholestyramine, per leflunomide prescribing label (ie. 8 g cholestyramine 3 times\n             daily for 11 days.\n\n             12. Subjects who have been previously treated with cyclosporine will require a 4-week\n             washout prior to randomization to participate in the study 13. If taking oral\n             corticosteroids, must be on a stable dose of prednisone less than or equal to 10\n             mg/day or equivalent for at least 30 days prior to baseline visit (ie, Day 0) 14. If\n             taking nonsteroidal anti-inflammatory drugs (NSAIDs) or narcotic analgesics, must be\n             on stable dose for at least 30 days prior to baseline visit (ie, Day 0) and until\n             they have completed the Week 24 study visit.\n\n             15. Must meet the following laboratory criteria:\n\n               -  White blood cell count greater than 3000/mm3 (greater than 3.0 X 109/L) and less\n                  than 14,000/mm3 (less than 14 X 109/L)\n\n               -  Platelet count at least 100,000/mm3 (at least 100 X 109/L)\n\n               -  Serum creatinine less than or equal to 1.5 mg/dL (less than or equal to 132.6\n                  \u03bcmol/L)\n\n               -  Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) less than or\n                  equal to twice upper limit of normal (ULN). If initial test shows ALT or AST\n                  greater than 2 times the ULN, one repeat test is allowed during the screening\n                  period.\n\n               -  Total bilirubin less than or equal to 2 mg/dL (less than or equal to 34 \u03bcmol/L)\n                  or Albumin greater than LLN. If initial test result is greater than 2 mg/dL, one\n                  repeat test is allowed during the screening period.\n\n               -  Hemoglobin at least 9 g/dL (at least 5.6 mmol/L)\n\n               -  Hemoglobin A1c less than or equal to 9.0% 16. All females of childbearing\n                  potential (FCBP) must use one of the approved contraceptive options as described\n                  below while on investigational product and for at least 28 days after\n                  administration of the last dose of the investigational product.\n\n        At the time of study entry, and at any time during the study when a female subject of\n        childbearing potential's contraceptive measures or ability to become pregnant changes, the\n        investigator will educate the subject regarding contraception options and the correct and\n        consistent use of effective contraceptive methods in order to successfully prevent\n        pregnancy.\n\n        Females of childbearing potential must have a negative pregnancy test at Screening and\n        Baseline.  All FCBP subjects who engage in activity in which conception is possible must\n        use one of the approved contraceptive options described below:\n\n        Option 1:  Any one of the following highly effective methods:  hormonal contraception\n        (oral, injection, implant, transdermal patch, vaginal ring); intrauterine device (IUD);\n        tubal ligation; or partner's vasectomy; OR Option 2:  Male or female condom (latex condom\n        or non latex condom NOT made out of natural [animal] membrane [for example, polyurethane];\n        PLUS one additional barrier method: (a) diaphragm with spermicide; (b) cervical cap with\n        spermicide; or (c) contraceptive sponge with spermicide.\n\n        17. Male subjects (including those who have had a vasectomy) who engage in activity in\n        which conception is possible must use barrier contraception (male latex condom or nonlatex\n        condom NOT made out of natural [animal] membrane [for example, polyurethane]) while on\n        investigational product and for at least 28 days after the last dose of investigational\n        product.\n\n        Exclusion Criteria:\n\n          -  - 1. History of clinically significant (as determined by the investigator) cardiac,\n             endocrine, pulmonary, neurologic, psychiatric, hepatic, renal, hematologic,\n             immunologic disease, or other major uncontrolled disease.\n\n             2. Any condition, including the presence of laboratory abnormalities, which places\n             the subject at unacceptable risk if he/she were to participate in the study or\n             confounds the ability to interpret data from the study.\n\n             3. Clinically significant abnormality on a 12-lead electrocardiogram (ECG) at\n             Screening.\n\n             4. Pregnant or breast feeding. 5. History of allergy to any component of the\n             investigational product. 6. Hepatitis B surface antigen positive at screening. 7.\n             Hepatitis C antibody positive at screening. 8. History of positive human\n             immunodeficiency virus (HIV), or congenital or acquired immunodeficiency (eg, Common\n             Variable Immunodeficiency Disease).\n\n             9. Active tuberculosis or a history of incompletely treated tuberculosis. 10.\n             Clinically significant abnormality based upon chest radiograph with at least\n             posterior-anterior (PA) view (the radiograph must be taken within 12 weeks prior to\n             Screening or during the Screening visit).  An additional lateral view is strongly\n             recommended but not required.\n\n             11. Active substance abuse or a history of substance abuse within 6 months prior to\n             Screening.\n\n             12. Bacterial infections requiring treatment with oral or injectable antibiotics, or\n             significant viral or fungal infections, within 4 weeks of Screening.  Any treatment\n             for such infections must have been completed and the infection cured, at least 4\n             weeks prior to Screening.\n\n             13. Malignancy or history of malignancy, except for:\n\n               1. treated [ie, cured] basal cell or squamous cell in situ skin carcinomas;\n\n               2. treated [ie, cured] cervical intraepithelial neoplasia [CIN] or carcinoma in\n                  situ of the cervix with no evidence of recurrence within the previous 5 years.\n\n                  14. Major surgery (including joint surgery) within 8 weeks prior to screening or\n                  planned major surgery within 6 months following randomization.\n\n                  15. Erythrodermic, guttate, or generalized pustular psoriasis at randomization.\n                  16. Rheumatic autoimmune disease other than PsA, including, but not limited to:\n                  systemic lupus erythematosis (SLE), mixed connective tissue disease (MCTD),\n                  scleroderma, polymyositis, or fibromyalgia.\n\n                  17. Functional Class IV, as defined by the American College of Rheumatology\n                  (ACR) Classification of Functional Status in Rheumatoid Arthritis.\n\n                  18. Prior history of or current inflammatory joint disease other than PsA (eg,\n                  gout, reactive arthritis, rheumatoid arthritis (RA), ankylosing spondylitis,\n                  Lyme disease).\n\n                  19. Prior treatment with more than one non-biologic DMARD 20. Use of the\n                  following systemic therapy(ies) within 4 weeks of randomization: cyclosporine or\n                  other calcineurin inhibitors, corticosteroids exceeding 10 mg daily prednisone\n                  equivalent, as well as other oral agents such as retinoids, mycophenolate,\n                  thioguanine, hydroxyurea, sirolimus, tacrolimus.\n\n                  21. Use of leflunomide within 12 weeks of randomization, unless subject has\n                  taken cholestyramine, 8g TID (three times a day) x 11 days after stopping\n                  leflunomide.\n\n                  22. Previous treatment with biologic agents for rheumatic diseases such as, but\n                  not limited to: adalimumab, abatacept, canakinumab, etanercept, golimumab,\n                  infliximab, rilonacept, certolizumab pegol, or tocilizumab.\n\n                  23. Previous treatment with biologic agents for dermatologic diseases such as\n                  alefacept, anti-TNFs (eg etanercept, adalinumab) or ustekinumab.\n\n                  24. Previous treatment with tofacitinib, Anti IL-17 agents or secukinumab 25.\n                  Previous treatment with any cell depleting therapies, including investigational\n                  agents (eg, rituximab, alemtuzumab, ocrelizumab, alemtuzumab, anti-CD4,\n                  anti-CD5, anti-CD3, anti-CD19, and anti-CD20).\n\n                  26. Treatment with intravenous gamma globulin, plasmapheresis, or Prosorba\u00ae\n                  column 27. Any previous treatment with alkylating agents such as\n                  cyclophosphamide or chlorambucil, or with total lymphoid irradiation.\n\n                  28. Prior treatment with any non-biologic DMARDS other than methotrexate,\n                  sulfasalazine, chloroquine, hydroxychloroquine, azathioprine, fumeric acid\n                  esters, cyclosporine, or leflunomide 29. Prior treatment with apremilast, or\n                  participation in a clinical study, involving apremilast 30. Use of any\n                  investigational drug within 4 weeks of randomization, or 5 pharmacokinetic/\n                  pharmacodynamic half lives, if known (whichever is longer)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "214", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01925768", 
            "org_study_id": "CC-10004-PSA-006"
        }, 
        "intervention": [
            {
                "arm_group_label": "Apremilast 30 mg", 
                "description": "30mg of Apremilast will be orally administered twice daily for 104 weeks", 
                "intervention_name": "Apremilast 30 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Identically appearing Placebo tablets will be orally administered twice daily for up to 24 weeks", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Apremilast, Psoriatic Arthritis, PDE4 inhibitor", 
        "lastchanged_date": "May 1, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35216"
                    }, 
                    "name": "Achieve Clinical Research LLC"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palm Desert", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92260"
                    }, 
                    "name": "Desert Medical Advances"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brandon", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33511"
                    }, 
                    "name": "Bay Area Arthritis and Osteoporosis"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brandon", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33511"
                    }, 
                    "name": "Health Point Medical Group"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hialeah", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33016"
                    }, 
                    "name": "Palmetto Medical Research"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naples", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34102"
                    }, 
                    "name": "Jeffrey Alper MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Port Richey", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34652"
                    }, 
                    "name": "Suncoast Clinical Research"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "University of South Florida"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Coeur D'alene", 
                        "country": "United States", 
                        "state": "Idaho", 
                        "zip": "83814"
                    }, 
                    "name": "Coeur D'alene Arthritis Clinic"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rockford", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "61107"
                    }, 
                    "name": "Rockford Orthopedic Associates LTD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lansing", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48910"
                    }, 
                    "name": "Advanced Rheumatology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kalispell", 
                        "country": "United States", 
                        "state": "Montana", 
                        "zip": "59901"
                    }, 
                    "name": "Kalispell Regional Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68134"
                    }, 
                    "name": "Heartland Clinical Research Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27834"
                    }, 
                    "name": "Physicians East PA"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27103"
                    }, 
                    "name": "Piedmont Medical Research LLC"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duncansville", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "16635"
                    }, 
                    "name": "Altoona Center for Clinical Research"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jackson", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38305"
                    }, 
                    "name": "West Tennessee Research Institute"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38119"
                    }, 
                    "name": "Ramesh C Gupta MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78731"
                    }, 
                    "name": "Austin Regional Clinic Far West Medical Tower"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75231"
                    }, 
                    "name": "Baylor Research Institute"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77090"
                    }, 
                    "name": "The Clinical Research Institute of Houston"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lubbock", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79424"
                    }, 
                    "name": "Arthritis and Osteoporosis Associates LLP"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84132"
                    }, 
                    "name": "University of Utah"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tacoma", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98405"
                    }, 
                    "name": "Tacoma Center for Arthritis Research, PS"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clarksburg", 
                        "country": "United States", 
                        "state": "West Virginia", 
                        "zip": "26301"
                    }, 
                    "name": "Mountain State Clinical Research"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Camperdown", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2050"
                    }, 
                    "name": "Royal Prince Alfred Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kogarah", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2217"
                    }, 
                    "name": "Optimus Clinical Research Pty Ltd"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westmead", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2145"
                    }, 
                    "name": "Westmead Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maroochydore", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4558"
                    }, 
                    "name": "Coast Joint Care"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hobart", 
                        "country": "Australia", 
                        "state": "Tasmania", 
                        "zip": "7000"
                    }, 
                    "name": "Menzies Research Institute"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Box Hill", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3128"
                    }, 
                    "name": "Eastern Health Clinical School"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "V6J 153"
                    }, 
                    "name": "Manna Research"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba", 
                        "zip": "R3A 1M3"
                    }, 
                    "name": "Manitoba Clinic"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint John's", 
                        "country": "Canada", 
                        "state": "Newfoundland and Labrador", 
                        "zip": "A1A 5E8"
                    }, 
                    "name": "Nexus Clinical Research"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint John's", 
                        "country": "Canada", 
                        "state": "Newfoundland and Labrador", 
                        "zip": "A1A 4Y3"
                    }, 
                    "name": "Karma Clinical Trials"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L8N 2B6"
                    }, 
                    "name": "Alfred Cividino's Private Practice"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ottawa", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "K1H 1A2"
                    }, 
                    "name": "Rheumatology Research Associates"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M9W 4L6"
                    }, 
                    "name": "Manna Research"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M9B 1B1"
                    }, 
                    "name": "Arthur Karasik Private Practice"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Windsor", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N8X 5A6"
                    }, 
                    "name": "Jude Rodrigues Private Practice"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec City", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "G1V 3M7"
                    }, 
                    "name": "Groupe de Recherche en Maladies Osseuses Inc."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sokolov", 
                        "country": "Czech Republic", 
                        "state": "Karlovarsk\u00fd kraj", 
                        "zip": "356 01"
                    }, 
                    "name": "Revmatologicka Ambulance"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha", 
                        "country": "Czech Republic", 
                        "state": "Praha, hlavn\u00ed mesto", 
                        "zip": "125 8"
                    }, 
                    "name": "Revmatologicky Ustav"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hostivice", 
                        "country": "Czech Republic", 
                        "state": "Praha-z\u00e1pad", 
                        "zip": "253 01"
                    }, 
                    "name": "ARTMEDI UPD s.r.o."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 4", 
                        "country": "Czech Republic", 
                        "zip": "140 00"
                    }, 
                    "name": "Revmatologicka Ambulance"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zlin", 
                        "country": "Czech Republic", 
                        "zip": "760 01"
                    }, 
                    "name": "PV - MEDICAL, s.r.o."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tallinn", 
                        "country": "Estonia", 
                        "state": "Harjumaa", 
                        "zip": "EE-11312"
                    }, 
                    "name": "East Tallinn Central Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tallinn", 
                        "country": "Estonia", 
                        "state": "Harjumaa", 
                        "zip": "EE-10117"
                    }, 
                    "name": "Innomedica"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tartu", 
                        "country": "Estonia", 
                        "state": "Tartumaa", 
                        "zip": "EE-50106"
                    }, 
                    "name": "Clinical Research Centre Ltd"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1036"
                    }, 
                    "name": "Qualiclinic Kft"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Debrecen", 
                        "country": "Hungary", 
                        "zip": "4032"
                    }, 
                    "name": "Debreceni Egyetem Orvos-\u00e9s Eg\u00e9szs\u00e9gtudom\u00e1nyi Centrum"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Szolnok", 
                        "country": "Hungary", 
                        "zip": "5000"
                    }, 
                    "name": "M\u00c1V K\u00f3rh\u00e1z \u00e9s Rendel\u00f6int\u00e9zet Szolnok"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Veszpr\u00e9m", 
                        "country": "Hungary", 
                        "zip": "8200"
                    }, 
                    "name": "Csolnoky Ferenc Korhaz"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Otahuhu", 
                        "country": "New Zealand", 
                        "state": "Auckland", 
                        "zip": "1640"
                    }, 
                    "name": "Middlemore Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Timaru", 
                        "country": "New Zealand", 
                        "state": "Canterbury", 
                        "zip": "7910"
                    }, 
                    "name": "Timaru Rheumatology Studies"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "New Zealand", 
                        "state": "Waikato", 
                        "zip": "3204"
                    }, 
                    "name": "Waikato Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cluj-Napoca", 
                        "country": "Romania", 
                        "state": "Cluj", 
                        "zip": "400006"
                    }, 
                    "name": "Cluj-Napoca Emergency Clinical County Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sfantu Gheorghe", 
                        "country": "Romania", 
                        "state": "Covasna", 
                        "zip": "520052"
                    }, 
                    "name": "Covamed SRL"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "011172"
                    }, 
                    "name": "\"Sf.Maria\" Clinical Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "10584"
                    }, 
                    "name": "SC Duo Medical SRL"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galati", 
                        "country": "Romania", 
                        "zip": "800578"
                    }, 
                    "name": "\"Sf. Apostol Andrei\" Emergency Clinical County Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kazan", 
                        "country": "Russian Federation", 
                        "zip": "420103"
                    }, 
                    "name": "Research Medical Complex Vashe Zdorovie"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nizhny Novgorod", 
                        "country": "Russian Federation", 
                        "zip": "603005"
                    }, 
                    "name": "Nizhniy Novgorod State Medical Academy"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Penza", 
                        "country": "Russian Federation", 
                        "zip": "440026"
                    }, 
                    "name": "Penza Regional Clinical Hospital n.a. N.N. Burdenko"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Smolensk", 
                        "country": "Russian Federation", 
                        "zip": "214025"
                    }, 
                    "name": "Departmental Hospital at Smolensk Station \"rzhd\" JSC"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yaroslavl", 
                        "country": "Russian Federation", 
                        "zip": "150062"
                    }, 
                    "name": "Yaroslavl Regional Clinical Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johannesburg", 
                        "country": "South Africa", 
                        "state": "Gauteng", 
                        "zip": "1619"
                    }, 
                    "name": "Clinresco Centre"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pretoria", 
                        "country": "South Africa", 
                        "state": "Gauteng", 
                        "zip": "181"
                    }, 
                    "name": "Jacaranda Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "state": "Western Cape", 
                        "zip": "7500"
                    }, 
                    "name": "Panorama Medical Centre"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "state": "Western Cape", 
                        "zip": "7925"
                    }, 
                    "name": "Groote Schuur Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Cuesta", 
                        "country": "Spain", 
                        "state": "Canarias", 
                        "zip": "38330"
                    }, 
                    "name": "Hospital Universitario de Canarias"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Badalona", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08035"
                    }, 
                    "name": "Hospital Universitario Vall d'Hebron"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hospitalet de Llobregat", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08907"
                    }, 
                    "name": "Hospital Universitari de Bellvitge"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sabadell", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08208"
                    }, 
                    "name": "Corporacio Sanitaria Parc Tauli"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago de Compostela", 
                        "country": "Spain", 
                        "state": "Galicia", 
                        "zip": "15706"
                    }, 
                    "name": "Hospital Clinico Universitario de Santiago"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bilbao", 
                        "country": "Spain", 
                        "state": "Vizcaya", 
                        "zip": "48013"
                    }, 
                    "name": "Hospital de Basurto Osakidetza"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "A Coru\u00f1a", 
                        "country": "Spain", 
                        "zip": "15006"
                    }, 
                    "name": "Complejo Hospitalario Universitario de A Coru\u00f1a"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }, 
                    "name": "Hospital Universitario La Paz"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain", 
                        "zip": "29009"
                    }, 
                    "name": "Hospital General de Malaga"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "Canada", 
                "Czech Republic", 
                "Estonia", 
                "Hungary", 
                "New Zealand", 
                "Romania", 
                "Russian Federation", 
                "South Africa", 
                "Spain"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis", 
        "overall_contact": {
            "email": "mawadalla@celgene.com", 
            "last_name": "Mark Awadalla, BS", 
            "phone": "732-652-6170"
        }, 
        "overall_official": {
            "affiliation": "Celgene Corporation", 
            "last_name": "Lilia Pineda, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Australia: Human Research Ethics Committee", 
                "Australia: National Health and Medical Research Council", 
                "Canada: Ethics Review Committee", 
                "Canada: Health Canada", 
                "Czech Republic: Ethics Committee", 
                "Czech Republic: State Institute for Drug Control", 
                "Estonia: Research Ethics Committee", 
                "Estonia: The State Agency of Medicine", 
                "Hungary: National Institute for Quality and Organizational Development in Healthcare and Medicines", 
                "New Zealand: Health and Disability Ethics Committees", 
                "New Zealand: Ministry of Health", 
                "Romania: Ethics Committee", 
                "Romania: National Agency for Medicines and Medical Devices", 
                "Russia: Ethics Committee", 
                "Russia: Ministry of Health of the Russian Federation", 
                "South Africa: National Health Research Ethics Council", 
                "South Africa: Human Research Ethics Committee", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Spain: Ethics Committee", 
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of subjects in each treatment group who achieve an ACR 20", 
            "measure": "American College of Rheumatology Score of 20% (ACR 20)", 
            "safety_issue": "No", 
            "time_frame": "Week 16"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01925768"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of participants with adverse events", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "104 Weeks"
            }, 
            {
                "description": "Change from baseline in physical function (Health Assessment Questionnaire-Disability Index [HAQ-DI] score) at Week 24", 
                "measure": "Physical function (Health Assessment Questionnaire-Disability Index [HAQ-DI] score)", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Proportion of subjects who achieve an ACR 20 at Week 24", 
                "measure": "American College of Rheumatology Score of 20% (ACR 20)", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Change from baseline in the Disease Activity Score (DAS28) at Week 24", 
                "measure": "Disease Activity Score (DAS28)", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Change in SF-36v2 physical functioning domain score at Week 24", 
                "measure": "Medical Outcome Study Short Form 36-Item Health Survey, Version 2 (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Change in SF-36v2 physical component summary score  at Week 24", 
                "measure": "Medical Outcome Study Short Form 36-Item Health Survey, Version 2 (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Change from baseline in duration /severity of morning stiffness at Week 24", 
                "measure": "Morning Stiffness", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Change from baseline in physical function (Health Assessment Questionnaire-Disability Index [HAQ-DI] score) at Week 16", 
                "measure": "Physical function (Health Assessment Questionnaire-Disability Index [HAQ-DI] score)", 
                "safety_issue": "No", 
                "time_frame": "16 Weeks"
            }, 
            {
                "description": "Change from baseline in the Disease Activity Score (DAS28) at Week 16", 
                "measure": "Disease Activity Score (DAS28)", 
                "safety_issue": "No", 
                "time_frame": "16 Weeks"
            }, 
            {
                "description": "Change in SF-36v2 physical functioning domain score at Week 16", 
                "measure": "Medical Outcome Study Short Form 36-Item Health Survey, Version 2 (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "16 Weeks"
            }, 
            {
                "description": "Change in SF-36v2 physical component summary score  at Week 16", 
                "measure": "Medical Outcome Study Short Form 36-Item Health Survey, Version 2 (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "16 Weeks"
            }, 
            {
                "description": "Change from baseline in duration /severity of morning stiffness at Week 16", 
                "measure": "Morning Stiffness", 
                "safety_issue": "No", 
                "time_frame": "16 Weeks"
            }, 
            {
                "description": "Proportion of subjects who achieve an ACR 20 at Week 52", 
                "measure": "American College of Rheumatology Score of 20% (ACR 20)", 
                "safety_issue": "No", 
                "time_frame": "52 Weeks"
            }, 
            {
                "description": "Proportion of subjects who achieve an ACR 20 at Week 104", 
                "measure": "American College of Rheumatology Score of 20% (ACR 20)", 
                "safety_issue": "No", 
                "time_frame": "104 Weeks"
            }, 
            {
                "description": "Change from baseline in physical function (Health Assessment Questionnaire-Disability Index [HAQ-DI] score) at Week 52", 
                "measure": "Physical function (Health Assessment Questionnaire-Disability Index [HAQ-DI] score)", 
                "safety_issue": "No", 
                "time_frame": "52 Weeks"
            }, 
            {
                "description": "Change from baseline in physical function (Health Assessment Questionnaire-Disability Index [HAQ-DI] score) at Week 104", 
                "measure": "Physical function (Health Assessment Questionnaire-Disability Index [HAQ-DI] score)", 
                "safety_issue": "No", 
                "time_frame": "104 Weeks"
            }, 
            {
                "description": "Change from baseline in the Disease Activity Score (DAS28) at Week 52", 
                "measure": "Disease Activity Score (DAS28)", 
                "safety_issue": "No", 
                "time_frame": "52 Weeks"
            }, 
            {
                "description": "Change from baseline in the Disease Activity Score (DAS28) at Week 104", 
                "measure": "Disease Activity Score (DAS28)", 
                "safety_issue": "No", 
                "time_frame": "104 Weeks"
            }, 
            {
                "description": "Change in SF-36v2 physical component summary score at Week 52", 
                "measure": "Medical Outcome Study Short Form 36-Item Health Survey, Version 2 (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "52 Weeks"
            }, 
            {
                "description": "Change in SF-36v2 physical component summary score  at Week 104", 
                "measure": "Medical Outcome Study Short Form 36-Item Health Survey, Version 2 (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "104 Weeks"
            }, 
            {
                "description": "Change from baseline in duration /severity of morning stiffness at Week 52", 
                "measure": "Morning Stiffness", 
                "safety_issue": "No", 
                "time_frame": "52 Weeks"
            }, 
            {
                "description": "Change from baseline in duration /severity of morning stiffness at Week 104", 
                "measure": "Morning Stiffness", 
                "safety_issue": "No", 
                "time_frame": "104 Weeks"
            }
        ], 
        "source": "Celgene Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Celgene Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}